TETON-2 Trial Results & IPF Impact: A Case Study

Created using ChatSlide

This conference presentation reviews TETON-2 in the context of idiopathic pulmonary fibrosis, a progressive disease with major unmet need. It summarizes the phase 3 trial of inhaled treprostinil, including design, endpoints, lung function outcomes, clinical worsening, and safety findings. The session highlights the observed FVC benefit, reduced progression risk, and practical considerations such as cough management, adherence, and shared decision-making. Attendees will gain a concise,...